日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Correction: HPV16-Expressing Tumors Release Multiple IL1 Ligands to Orchestrate Systemic Immunosuppression Whose Disruption Enables Efficacy of a Therapeutic Vaccine

更正:表达HPV16的肿瘤释放多种IL-1配体,从而协调全身免疫抑制,而破坏这种抑制作用可使治疗性疫苗发挥疗效。

Lecointre, Morgane; Guillot, Jérémy; Marcone, Rachel; Ozdoganlar, Dilara; Cayatte, Marjorie; Gyllenbäck, Elin Jaensson; Liberg, David; Fournier, Nadine; Homicsko, Krisztian; Hanahan, Douglas

Biomarkers of activity from a phase I study of cergutuzumab amunaleukin in patients with advanced solid tumors

一项针对晚期实体瘤患者的 cergutuzumab amunaleukin I 期研究的活性生物标志物

Melero, Ignacio; Steeghs, Neeltje; Lassen, Ulrik; Homicsko, Krisztian; Tabernero, Josep; Cañamero, Marta; Roller, Andreas; Duarte, José; Rossmann, Eva; Babitzki, Galina; Grabole, Nils; Watson, Carl; Habigt, Christin; Evers, Stefan; Dejardin, David; Teichgräber, Volker; Charo, Jehad

Transcriptome analysis of archived tumors by Visium, GeoMx DSP, and Chromium reveals patient heterogeneity.

利用 Visium、GeoMx DSP 和 Chromium 对存档肿瘤进行转录组分析,揭示了患者的异质性

Dong Yixing, Saglietti Chiara, Bayard Quentin, Espin Perez Almudena, Carpentier Sabrina, Buszta Daria, Tissot Stephanie, Dubois Rémy, Kamburov Atanas, Kang Senbai, Haignere Carla, Sarkis Rita, Andre Sylvie, Alexandre Gaveta Marina, Lopez Lastra Silvia, Piazzon Nathalie, Santos Rita, von Loga Katharina, Hoffmann Caroline, Coukos George, Peters Solange, Soumelis Vassili, Durand Eric Yves, de Leval Laurence, Gottardo Raphael, Homicsko Krisztian, Madissoon Elo

Case Report: Lasting complete response to pembrolizumab in mismatch repair-deficient cardiac sarcoma: a genomic characterization

病例报告:帕博利珠单抗治疗错配修复缺陷型心脏肉瘤获得持久完全缓解:基因组特征分析

Ferraro, Daniela A; Bisig, Bettina; Rotzinger, David C; Pareja, Fresia; Missiaglia, Edoardo; Voutsadakis, Ioannis; Homicsko, Krisztian; Digklia, Antonia

Tissue specificity and chromosomal alterations shape divergent immune programs in HRD tumors

组织特异性和染色体改变塑造了HRD肿瘤中不同的免疫程序

Gulhan, Doga C; Barras, David; Mina, Marco; Ghisoni, Eleonora; Kim, Yoo-Na; Viswanadham, Vinay; Jin, Hu; Huber, Florian; Homicsko, Krisztian; Bassani-Sternberg, Michal; Ciriello, Giovanni; Park, Peter J; Dangaj Laniti, Denarda

iPSC-derived and Patient-Derived Organoids: Applications and challenges in scalability and reproducibility as pre-clinical models

诱导多能干细胞衍生和患者来源的类器官:作为临床前模型在可扩展性和可重复性方面的应用与挑战

Heinzelmann, Elisa; Piraino, Francesco; Costa, Mariana; Roch, Aline; Norkin, Maxim; Garnier, Virginie; Homicsko, Krisztian; Brandenberg, Nathalie

PD-1-expressing macrophages and CD8 T cells are independent predictors of clinical benefit from PD-1 inhibition in advanced mesothelioma

表达PD-1的巨噬细胞和CD8 T细胞是晚期间皮瘤患者从PD-1抑制剂治疗中获益的独立预测因子。

Homicsko, Krisztian; Zygoura, Panagiota; Norkin, Maxim; Tissot, Stephanie; Shakarishvili, Nicholas; Popat, Sanjay; Curioni-Fontecedro, Alessandra; O'Brien, Mary; Pope, Anthony; Shah, Riyaz; Fisher, Patricia; Spicer, James; Roy, Amy; Gilligan, David; Rusakiewicz, Sylvie; Fortis, Ekaterina; Marti, Nesa; Kammler, Roswitha; Finn, Stephen P; Coukos, Georges; Dafni, Urania; Peters, Solange; Stahel, Rolf A

Response and Resistance to Trametinib in MAP2K1-Mutant Triple-Negative Melanoma

MAP2K1突变型三阴性黑色素瘤对曲美替尼的反应和耐药性

Krebs, Fanny Seraphine; Moura, Bianca; Missiaglia, Edoardo; Aedo-Lopez, Veronica; Michielin, Olivier; Tsantoulis, Petros; Bisig, Bettina; Trimech, Mounir; Zoete, Vincent; Homicsko, Krisztian

Deep and lasting response and acquired resistance to BRAFV600E targeting in a low-grade ovarian cancer patient

低级别卵巢癌患者对BRAFV600E靶向治疗产生深度持久反应和获得性耐药

Anchisi, Sandro; Wolfer, Anita; Bisig, Bettina; Missiglia, Edoardo; Tiab, Amine; Kamel, Ehab Mohamed; Michielin, Olivier; Coukos, George; Homicsko, Krisztian

Exceptional response to PD-1 inhibition immunotherapy in advanced metastatic osteosarcoma with tumor site infection

晚期转移性骨肉瘤伴肿瘤部位感染对PD-1抑制免疫疗法反应显著

Digklia, Antonia; Boughdad, Sarah; Homicsko, Krisztian; Dromain, Clarisse; Trimech, Mounir; Dolcan, Ana; Peters, Solange; Prior, John; Schaefer, Niklaus; Li, Meng; Bao, Qiyuan; Zhang, Zhusheng; Wang, Beichen; Liu, Zhuochao; Wen, Junxiang; Wan, Rong; Shen, Yuhui; Zhang, Weibin